AI Verdict
IBO has stronger fundamentals based on our AI analysis.
ICHR vs IBO Fundamental Comparison
| Metric | ICHR | IBO |
|---|---|---|
| Revenue | $947.7M | $32,000.0 |
| Net Income | $-52.8M | $-11.8M |
| Net Margin | -5.6% | -36,993.8% |
| ROE | -8.0% | -93.9% |
| ROA | -5.6% | -68.0% |
| Current Ratio | 3.16x | 0.35x |
| Debt/Equity | 0.19x | 0.00x |
| EPS | $-1.54 | $-0.38 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ICHR vs IBO: Frequently Asked Questions
Is ICHR or IBO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IBO has stronger fundamentals. ICHR is rated STRONG SELL (78% confidence) while IBO is rated STRONG SELL (95% confidence). This is not investment advice.
How does ICHR compare to IBO fundamentally?
ICHOR HOLDINGS, LTD. has ROE of -8.0% vs IMPACT BIOMEDICAL INC.'s -93.9%. Net margins are -5.6% vs -36,993.8% respectively.
Which stock pays higher dividends, ICHR or IBO?
ICHR has a dividend yield of N/A or no dividend while IBO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ICHR or IBO for long term?
For long-term investing, consider that ICHR has STRONG SELL rating with 78% confidence, while IBO has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ICHR vs IBO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ICHR vs IBO, the AI consensus favors IBO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.